4//SEC Filing
WG Biotech ApS 4
Accession 0001104659-21-077702
CIK 0001722964other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:30 PM ET
Size
7.0 KB
Accession
0001104659-21-077702
Insider Transaction Report
Form 4
WG Biotech ApS
Director10% Owner
Transactions
- Sale
Common Stock
2021-06-04$34.03/sh−3,841$130,704→ 4,412,094 total - Sale
Common Stock
2021-06-03$33.19/sh−30,666$1,017,670→ 4,415,935 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $33.165 to $34.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $34.00 to $34.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
IncorporatedDenmark
Related Parties
1- filerCIK 0001753193
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:30 PM ET
- Size
- 7.0 KB